Acute lung injury (ALI) is defined as an inflammatory lung condition that is mediated by the interplay between inflammatory cells such as phagocytes, in particular macrophages and neutrophils, and non-immune cells such as alveolar epithelial cells. 1, 2) Because the overall risk of mortality for ALI or acute respiratory distress syndrome (ARDS) patients remains unacceptably high, an improved understanding of the pathophysiology is needed to reduce mortality through the development of treatments that will be additive or synergistic with mechanical ventilation strategies using low tidal volumes.
Acute lung injury (ALI) is defined as an inflammatory lung condition that is mediated by the interplay between inflammatory cells such as phagocytes, in particular macrophages and neutrophils, and non-immune cells such as alveolar epithelial cells. 1, 2) Because the overall risk of mortality for ALI or acute respiratory distress syndrome (ARDS) patients remains unacceptably high, an improved understanding of the pathophysiology is needed to reduce mortality through the development of treatments that will be additive or synergistic with mechanical ventilation strategies using low tidal volumes. 3) Recently, the several investigators have proposed that lung epithelial cell death occurs not only through necrotic processes, such as through ischemic change or direct disruption, but also by apoptotic processes. 1, 4, 5) Apoptosis, a form of programmed cell death characterized by nuclear condensation and endonuclease-mediated DNA fragmentation, is essential to tissue development and preservation of cell membrane integrity. Apoptosis also appears to be important in the pathophysiology of some diseases. [6] [7] [8] [9] The Fas-Fas ligand (FasL) system comprises an important mechanism for regulating apoptotic cell death. The Fas antigen (CD95, APO-1) belongs to a conserved family of membrane receptors known as the tumor necrosis factor (TNF) receptor family, 10) and is expressed on various cells and tissues, including thymus, liver, heart, and lung. FasL is a type II integral membrane protein of the TNF family. 11) Membranebound FasL is cleaved by specific matrix metalloproteinases to produce its soluble form. 12) Although expression of FasL was originally thought to be limited to cytotoxic T cells, it also has been found in other types of cells.
11) Polymorphonuclear neutrophils (PMN) release soluble FasL, which can induce apoptosis in certain Fas bearing cell types, including PMN themselves. 13, 14) High levels of preformed FasL are found in the intracellular compartment, and stimulation of monocytic cells by phytohaemagglutinin or superantigen gives rise to the rapid release of soluble FasL. 15) Binding of FasL to Fas antigen causes apoptosis in Fas antigen-bearing cells via an apoptotic pathway that is dependent on the initiator caspase-8. 16) Cross-linking of the extracellular domains of Fas by FasL results in Fas trimerization and intracellular recruitment of the adapter molecule Fas-associated death domain protein (FADD) to the receptor cluster. Recruitment is facilitated by homotypic interaction between death domains located in Fas and FADD. Receptorbound FADD oligomerizes and utilizes a second domain, the death effector domain, to recruit procaspase-8, forming the Fas/FADD/procaspase-8 complex known as the death-inducing signaling-complex (DISC). 17, 18) DISC catalyzes the proteolytic conversion of procaspase-8 into active caspase-8, which activates the downstream effector caspases, triggering cell death. Apoptosis also occurs via a mitochondria-mediated process, which begins with mitochondrial permeability transition, followed by the release of apoptogenic factors such as cytochrome c and apoptosis-inducing factor. 19, 20) The initiator caspase-9 then becomes activated through the formation of the cytochrome c/Apaf-1/procaspase-9-containing apoptosome complex in the cytosol, leading to the activation of downstream effector caspases. 21) We previously demonstrated a crucial role for alveolar macrophages in inflammatory response associated with lung 
MATERIALS AND METHODS
Cell Culture Human lung adenocarcinoma A549 and human monocytic leukemia THP-1 were obtained from the American Type Culture Collection (Manassas, VA, U.S.A.) and European Collection of Cell Culture (Wiltshire, U.K.), respectively. A549 was cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin, and 100 mg/ml streptomycin at 37°C in 5% CO 2 atmosphere. THP-1 was cultured in RPMI 1640 supplemented with 10% FBS, penicillin (100 units/ml), streptomycin (100 mg/ml), and 2 mM glutamine in an atmosphere of 5% CO 2 at 37°C. A549 and THP-1 cultures were plated at 80-90% confluence in 25 cm 2 tissue culture flasks (Falcon/Fisher, Pittsburgh, PA, U.S.A.). Before further manipulation, cells were incubated for 3 d after passage to allow them to reach full confluence and a resting state.
Antibodies and Chemicals LPS (from Escherichia coli O55 : B5) was obtained from Sigma (St. Louis, MO, U.S.A.). Z-DEVD-FMK and Z-IETD-FMK were purchased from Enzyme Systems (Livermore, CA, U.S.A.). Antibodies for the active forms of caspase-3, -8, and -9 were from MBL (Nagoya, Japan), and that for b-actin from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.).
Preparation of Conditioned Medium THP-1 cells (1ϫ10 6 cells/ml) were cultured for 24 h with or without LPS (10 mg/ml). The culture supernatant was harvested and centrifuged at 500 g for 10 min to remove cells and debris. The resulting conditioned medium (CM) was used immediately after harvesting.
Enzyme-Linked Immunosorbent Assay (ELISA) for FasL FasL concentration in the culture supernatant was measured by FasL ELISA kits (MBL), according to the manufacturer's protocol. The limit of detection was 40 pg/ml.
Quantification of Fas Expression A549 cells were detached from the culture dish with non-enzymatic cell dissociation solution (Sigma) and incubated with a monoclonal phycoerythrin (PE)-conjugated anti-human CD95 antibody or isotype-matched PE-conjugated control antibody (BD Biosciences, San Jose, CA, U.S.A.) diluted with staining buffer (10% FBS in phosphate buffered saline, pH 7.4, Sigma) for 30 min at 4°C. Cells were washed thoroughly three times with staining buffer. Fluorescence intensity was quantified by FACS Caliber Flow Cytometer (Becton Dickinson, Franklin Lakes, NJ, U.S.A.).
MTT-Dye Reduction Assay Cell viability was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 26) Cells were incubated with 1 mg/ml MTT for 4 h, the medium was removed, and 100 ml of 0.04 M HCl in isopropanol was added to extract the reduced formazan product. The resulting optical density at 590 nm was determined.
Western Blotting Immunodetection was performed as described previously. 27) Briefly, cells were lysed in 50 ml loading buffer (120 mM Tris, 4% SDS, 20% glycerol, 0.1 mg/ml bromophenol blue, pH 6.8) containing 100 mM dithiothreitol and boiled for 5 min. Each sample (50 mg protein) was resolved on SDS-PAGE (16% acrylamide for active caspase-3, and 12% acrylamide for active caspase-8, and -9). Proteins in each gel were transferred to an Immobilon-P membrane (Milipore, Bedford, MA, U.S.A.). Blots were blocked for 1 h with 5% nonfat dry milk and probed with the indicated primary antibodies for 1 h and then with the appropriate horseradish peroxidase-conjugated secondary antibody (MBL, Nagoya, Japan). Signals were visualized by fluorescence emission using commercial detection kits (GE Healthcare, Tokyo, Japan) according to the manufacturer's instructions.
RNA Interference A549 and THP-1 cells were transfected by nucleofection using Nucleofector (Amaxa GmbH, Cologne, Germany). A549 cells (5ϫ10 5 cells) were suspended in 100 ml pre-warmed Nucleofector Solution Kit T containing 10 mg of Fas inhibition vector (Invitrogen, Tokyo, Japan). THP-1 cells (5ϫ10 5 cells) were suspended in 100 ml prewarmed Nucleofector Solution Kit V containing 10 mg of FasL inhibition vector (Invitrogen). A549 cells were transfected with the electrical setting X-001, THP-1 cells with the electrical setting V-01. After the transfection, the cells were transferred immediately into prewarmed complete medium for further experiments.
Assay for Apoptotic Morphology Cells were fixed with 4% paraformaldehyde for 20 min and stained with 8 mg/ml Hoechst 33342. Cell morphology was observed using a fluorescence microscope (Olympus, Tokyo, Japan) in the presence of 10 mg/ml propidium iodide (PI).
Statistical Analysis One-way analysis of variance for factorial experiments was used, followed by Student-Newman-Keuls's procedure for post hoc multicomparison analysis among the groups.
RESULTS
Caspase-8-Dependent Apoptosis of A549 Cells Induced by Lipopolysaccharide-Stimulated THP-1 Conditioned Medium To model the lung injury system in vitro, a human monocyte cell line, THP-1, was cultured in the presence or absence of LPS, and the resulting conditioned medium (CM) was added to a human lung epithelial cell line, A549, that was stimulated with LPS for 24 h. Viability of A549 cells was determined by MTT assay 24 h after the addition of CM. LPS-stimulated THP-1 CM significantly reduced the viability of A549 cells while incubation in non-stimulated THP-1 CM for 24 h hardly affected the viability of A549 cells (Fig. 1A) . The LPS used in this experiment (10 mg/ml) had no effect on the cell viability of A549 cells or THP-1 cells (data not shown), eliminating the possibility of direct cytotoxicity of LPS to these cell lines.
To confirm that the reduction of cell viability was due to apoptosis, we determined caspase activation using specific antibodies for the active forms of the caspases. Caspase-8 is an initiator caspase in the Fas-mediated apoptotic pathway, and caspase-3 is one of the effector caspases downstream of the initiator caspase.
28) Procaspase-3 (32 kDa) and procaspase-8 (55 kDa) are cleaved to form active caspase-3 (17 kDa) and active caspase-8 (18 kDa) upon the onset of apoptosis. CM from LPS-stimulated THP-1 cells significantly increased the active forms of these caspases in A549 cells, and the increase was completely suppressed by the addition of specific inhibitors for caspase-3, Z-DEVD-FMK, and caspase-8, Z-IETD-FMK (Fig. 1B) .
Consistent with the results of Western blotting, these inhibitors completely suppressed reduction of A549 viability in the presence of LPS-stimulated THP-1 CM (Fig. 1A) . In contrast, caspase-9, an initiator caspase downstream of the mitochondria-dependent apoptotic pathway, was not activated by CM from LPS-stimulated THP-1 (data not shown). These results suggest that THP-1 secretes a factor that causes DISC-dependent apoptosis in response to LPS-stimulation. It should be noted that inhibition of caspase-3 suppressed cleavage of caspase-3 as well as that of the upstream initiator caspase, caspase-8. This implies the existence of a positive feedback loop in the DISC-dependent activation cascade in which caspase-3 cleaves procaspase-8 and -9 to release their active forms. 29, 30) We further confirmed the apoptotic character of A549 cells treated with LPS-stimulated THP-1 CM through observation of the nuclear morphology of cells stained with Hoechst 33342 and propidium iodide (PI). A549 cells incubated with LPS-stimulated THP-1 CM had fragmented and/or condensed chromatin, one of the characteristic features of apoptotic cells, 6) as compared to cells cultured in non-stimulated THP-1 CM for 24 h, which had rounded, intact nuclei (Fig.  2) . It should be noted that a fraction of the apoptotic cells excluded PI, suggesting that apoptosis occurs without impairing membrane permeability in these cells. This result indicates that LPS-stimulated THP-1 CM reduces cell viability mainly through the apoptosis in human lung epithelial cells. Consistent with the results of MTT assay and Western blotting (Fig. 1) , the induction of apoptotic morphology by LPSstimulated THP-1 CM was completely suppressed by addition of the capspase-3 inhibitor Z-DEVD-FMK, suggesting that this process is also dependent on activation of effector caspases. The caspase inhibitor prevented destruction of cell permeability induced by LPS-stimulated THP-1 CM as detected by PI-staining. This observation again suggests that reduction of cell viability occurs mainly through apoptosis.
Apoptosis of A549 Cells Induced by Lipopolysaccharide-Stimulated THP-1 Conditioned Medium Is Mediated by Fas/FasL-Interaction It is reported that monocytes produce a high level of FasL in response to immune complex, phytohaemagglutinin, and superantigen. 15) We have demonstrated that FasL-positive inflammatory cells migrate into the airspaces of LPS-instilled lung in the murine experimental model. 24) Thus, one of the candidates for apoptosis induction in LPS-stimulated THP-1 CM is soluble FasL. To confirm this premise, we quantified FasL in the conditioned medium by ELISA and found that THP-1 cells secreted a significant amount of FasL in the medium as early as 6 h after LPS-stimulation (Fig. 3) . FasL production reached a maximum-level 24 h after LPS stimulation and remained at that level until at least 72 h after stimulation. THP-1 cells without LPS stimulation did not produce a detectable amount of FasL (Fig. 3 , open circles). A549 cells did not produce FasL even in the presence of LPS (data not shown).
These results suggest that THP-1 cells kill A549 cells through the apoptosis induced by Fas antigen stimulated with FasL secreted in response to LPS. Loss-of-function experiments using small interfering RNA (siRNA) provide further evidence for this theory. Gene targeting on FasL in THP-1 cells by specific siRNA transfection significantly reduced FasL secretion in response to LPS (Fig. 3) , while transfection of A549 cells with Fas-specific siRNA significantly reduced surface Fas expression (Fig. 4A) . LPS-stimulation increased Fas-expression of A549 cells, consistent with the observation that pretreatment of A549 cells with LPS (10 mg/ml) enhances CM-mediated cytotoxicity (data not shown). Fas depletion in LPS-stimulated A549 cells by siRNA reduced the Fas expression to the level in non-stimulated cells. FasLsiRNA transfection of THP-1 significantly reduced the ability of CM from LPS-stimulated cells to decrease the viability of A549 cells (Fig. 4B) . Conversely, transfection of A549 cells with Fas-siRNA significantly reduced the sensitivity to A549 cells to LPS-stimulated THP-1 CM. These results suggest that Fas-FasL interaction plays a crucial role in the apoptosis of A549 cells caused by CM from LPS-stimulated THP-1 cells.
DISCUSSION
The main goal of this study was to determine whether the mechanism of epithelial damage could be related to epithelial cell apoptosis mediated by FasL present in the airspaces. We found that a human monocytic cell line, THP-1, stimulated by LPS released a significant amount of FasL. Furthermore, the expression of Fas on the cell membrane of the human pulmonary adenocarcinoma cell line A549 is enhanced upon stimulation with LPS. When the supernatant of LPS-stimulated THP-1 cells was co-incubated with A549 cells, a marked apoptotic cell death dependent on the DISCpathway was observed. Inhibition of Fas expression in A549 cells or inhibition of FasL expression in THP-1 cells by specific siRNA attenuated the cell death significantly. Taken together, these results suggest that human monocytes secrete FasL upon the inflammatory response, which subsequently injures lung epithelial cells through the apoptosis caused by the stimulation of Fas antigen on the lung epithelial cells.
We previously reported up-regulation of proapoptotic molecules such as Fas and FasL in BAL cells from patients in the acute phase of septic ARDS. 5) Other groups have reported that FasL is upregulated in BAL fluid from adult patients with ARDS compared with levels in normal control subjects, with the highest levels occurring during the first week of illness. 4, 25) The studies using Fas-deficient lpr mice and FasLdeficient gld mice, showed that Fas-FasL interaction plays a crucial role in the development of LPS-induced ALI. 31) In addition, we found that the expression of Fas was seen in alveolar wall cells as well as in the infiltrating PMN and alveolar macrophages, while expression of FasL was limited to the macrophage-like cells in the airspace in a murine model of LPS-induced ALI.
24) The present results provide further in vitro evidence demonstrating that monocytes are a major source of FasL in the promotion of ALI.
It is known that monocytes express both Fas and FasL on their surfaces, and the interaction of these molecules induces spontaneous apoptosis. 15) Inflammatory stimulation with immune complex, phytohaemagglutinin, or superantigen as well as phagocytosis of apoptotic PMN gives rise to the rapid release of soluble FasL from the monocytes. 15, 32) Elimination of inflammatory cells through the spontaneous apoptosis promoted by accelerated FasL secretion is proposed to be one of the mechanisms for resolution of inflammatory response in ALI. 1, 32) On the other hand, our results demonstrate that monocytes evoke lung injury by inducing apoptosis of lung epithelial cells. Monocytes produce proinflammatory cytokines including IL-8 and TNFa upon Fas ligation through the activation of nuclear transcription factor NFkB and promote PMN migration into the inflammatory site. 33) PMN is another source of soluble FasL which enhances apoptotic injury of lung epithelium. 13) This positive feedback loop may accelerate the inflammatory response, further enhancing the development of ALI. It is clear that Fas-FasL interaction plays a crucial role in the pathogenesis of ALI. The proper regulation of the Fas-FasL system might provide a potential therapeutic strategy for human ALI. 
